MetaCap

K2 Capital Acquisition (KTWO) vs Treace Medical Concepts (TMCI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

Treace Medical Concepts is the larger company by market cap ($253.0 million vs $201.8 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

KTWO+2.03%TMCI+85.24%
+141%+45%-52%
Feb 26, 20261 yearOct 7, 2026
KTWO+2.13%TMCI+109.14%
+168%+62%-44%
Feb 23, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

KTWO versus TMCI key metrics
MetricKTWOTMCI
Share price$10.07$3.89
Market cap$201.81M$252.98M
1-day change-0.20%-2.75%
YTD return—+58.78%
1-year return—-35.17%
5-year return—-84.07%
EPS (TTM)—$-0.92
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$10.10$7.08
52-week low$9.84$1.17
Distance from 52-week high-0.30%-45.06%
Average volume29.51K333.87K
Shares outstanding14.13M65.03M
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

KTWO vs TMCI FAQ

Which is bigger, K2 Capital Acquisition or Treace Medical Concepts?

Treace Medical Concepts (TMCI) is larger, with a market capitalization of $252.98M compared with $201.81M for K2 Capital Acquisition (KTWO).

Are K2 Capital Acquisition and Treace Medical Concepts in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons